Halobetasol
Halobetasol.svg | |
Halobetasol is a corticosteroid used in the treatment of various skin conditions. It is a potent topical steroid that is primarily used to reduce inflammation and relieve itching associated with skin disorders such as psoriasis and eczema.
Pharmacology[edit | edit source]
Halobetasol is classified as a super-high potency corticosteroid. It works by activating natural substances in the skin to reduce swelling, redness, and itching. The drug is available in various forms, including creams, ointments, and lotions, and is typically applied to the affected area of the skin.
Mechanism of Action[edit | edit source]
Halobetasol exerts its effects by binding to the glucocorticoid receptor in the cytoplasm of cells. This binding leads to the translocation of the receptor-steroid complex into the nucleus, where it influences the transcription of specific genes. The result is a decrease in the production of inflammatory mediators such as prostaglandins and leukotrienes, leading to reduced inflammation and immune response.
Clinical Uses[edit | edit source]
Halobetasol is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. It is often prescribed for short-term use due to its potency and the risk of side effects with prolonged use.
Dosage and Administration[edit | edit source]
The typical dosage involves applying a thin layer of the medication to the affected area once or twice daily. The duration of treatment is usually limited to two weeks, and the total dosage should not exceed 50 grams per week.
Side Effects[edit | edit source]
Common side effects of halobetasol include burning, itching, irritation, and dryness at the application site. Prolonged use can lead to more serious side effects such as skin thinning, stretch marks, and systemic absorption leading to Cushing's syndrome.
Precautions[edit | edit source]
Patients should use halobetasol with caution, especially in sensitive areas such as the face, groin, or underarms. It should not be used in patients with known hypersensitivity to corticosteroids or any component of the formulation.
Also see[edit | edit source]
References[edit | edit source]
- "Halobetasol Propionate." Drugs.com. Accessed October 2023.
- "Topical Corticosteroids: Mechanism of Action and Clinical Applications." Journal of Dermatology.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD